ENTITY
Ensysce Biosciences

Ensysce Biosciences (ENSC US)

22
Analysis
Health Care • United States
Ensysce Biosciences, Inc. operates as a clinical stage biotech company. The Company focuses on stemming the prescription drug abuse epidemic. Ensysce Biosciences serves customers worldwide.
more
bullish•Ensysce Biosciences
•14 Nov 2024 01:00•Issuer-paid

ENSC: Results Show Solid Cash and Good Prospects

Ensysce Biosciences is committed to finding a solution to the opioid crisis plaguing the US and other developed countries around the...

Share
bullish•Ensysce Biosciences
•31 Aug 2024 01:00•Issuer-paid

ENSC: Substantial Federal Funds Granted

Ensysce Biosciences is committed to finding a solution to the opioid crisis plaguing the US and other developed countries around the...

Share
bullish•Ensysce Biosciences
•27 Aug 2024 23:00•Issuer-paid

ENSC: Substantial Federal Funds Granted

Ensysce Biosciences is committed to finding a solution to the opioid crisis plaguing the US and other developed countries around the...

Share
bullish•Ensysce Biosciences
•16 Aug 2024 01:00•Issuer-paid

ENSC: 2Q Release Sets Stage for Important Trials

Ensysce Biosciences is committed to finding a solution to the opioid crisis plaguing the US and other developed countries around the...

Share
bullish•Ensysce Biosciences
•14 May 2024 00:00•Issuer-paid

ENSC: 1Q Release Highlights Financial and Scientific Progress

Ensysce Biosciences is committed to finding a solution to the opioid crisis plaguing the US and other developed countries around the...

Share
x